Investor · Cambridge, MA

Keith Flaherty

Open Keith in the network graph →

Filings

12

SEC Form D

Connections

98

co-filers

Capital

$111.1M

across filings

Active

Jul 2013

to Jun 2020

Most-connected co-filers (98)

Robert Weisskoff · Berkeley, CA6 shared Alan Fuhrman · Cambridge, MA6 shared Jonathan Lieber · Cambridge, MA6 shared Kleem Chaudhary · Cambridge, MA6 shared James Wooldridge · Cambridge, MA5 shared Keith Flaherty · Pembroke, MA4 shared Donald P. Martin · Reston, VA3 shared Arthur M. Krieg · Cambridge, MA3 shared Habib Y. Gorgi · PROVIDENCE, RI3 shared Charles M. Yon · Cambridge, MA3 shared Timothy Murphy · Des Moines, IA3 shared C. R. Mullet · Reston, VA3 shared Barry Labinger · Cambridge, MA3 shared Jack Honour · Las Vegas, NV3 shared James M. Wilmott · New York, NY3 shared Jing Hong · Hong Kong, Israel3 shared Karen Brennan · Cambridge, MA3 shared Corey M. Goodman · Cambridge, MA3 shared Steve Berman · Atlanta, GA3 shared Michael J. Powell · Billerica, MA3 shared Anna Marie S. Lopez · LOS ANGELES, CA3 shared Scott H. Mcbride · LOS ANGELES, CA3 shared Arthur Reidel · San Martin, CA3 shared Andrew F. Medvedev · New York, NY3 shared

Recent filings (12)

Antares Therapeutics, Inc.May 2025 · 18 co-filers$136.7M Scorpion Therapeutics, Inc.Jul 2024 · 29 co-filers$150.0M C-REVEAL THERAPEUTICS LLCDec 2020 · 7 co-filers$3.3M Checkmate Pharmaceuticals, Inc.Jun 2020 · 38 co-filers$100.1M Home EC Inc.Jun 2020 · 10 co-filers$10.8M Checkmate Pharmaceuticals, Inc.Apr 2020 · 38 co-filers$10.0M Checkmate Pharmaceuticals, Inc.Jan 2020 · 38 co-filers$16.0M Home Ec Inc.Oct 2018 · 8 co-filers$8.0M Sharp Edge Labs, Inc.Oct 2018 · 17 co-filers$550K Sharp Edge Labs, Inc.Jul 2017 · 11 co-filers$2.4M Clovis Oncology, Inc.Nov 2013 · 18 co-filers Sharp Edge Labs, Inc.Jul 2013 · 9 co-filers$250K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Keith in the interactive graph →